UNSPSC 51101642: Calcium trisodium pentetate

This classification denotes a metal chelator with the molecular formula C14H18N3O10.Ca.3Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G79YN26H5B, chemically known as trisodium (n,n-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))calciate(3-) but generally known as calcium trisodium pentetate, which bears US NIH Compound Identifier 6328163. European Medicines Agency schedules Calcium trisodium pentetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13204MIG.

The term CALCIUM TRISODIUM PENTETATE is an International Non-Proprietary Name. Most nations schedule calcium trisodium pentetate under HS 29224995 and SITC 51465. SMILES: [Ca]12345OC(=O)CN4(CCN3(CCN5(CC(=O)O2)CC(=O)O)CC(=O)O)CC(=O)O1.[Na].[Na].[Na].

UNSPSC 51101642 Calcium trisodium pentetate is a Commodity code that nominally identifies a specific pharmaceutical chelating agent, but recent state and local opportunities posted under this code do not align with that narrow product scope. The opportunities being solicited are medical and pharmaceutical supplies of much broader scope—naloxone and drug deactivation systems, first aid and emergency medical supplies for fire rescue operations, and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing. The mismatch between the code's nominal product and the work actually being bought suggests the code sees limited or misclassified recent activity. Issuing bodies posting opportunities tagged to this code include county health departments, city fire and purchasing departments, state health and human services agencies, and multistate cooperative purchasing alliances. The range of entities reflects typical state and local procurement patterns for medical and pharmaceutical supplies, though the small number of recent opportunities suggests either low activity concentration or potential classification drift within procurement systems.

Geographic activity appears concentrated in Florida, Texas, Minnesota, and Oregon based on the recent opportunities. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a July 26, 2023 response deadline. The City of Tampa posted ITB 26P00145 on March 25, 2026 for medical and first aid supplies (169 line items) for the Fire Department Rescue Division, designated as a sheltered market opportunity for certified Small Local Business Enterprises with an estimated contract value of $700,000.00 and a March 13, 2026 response deadline. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, posted RFP S1070000015802 on January 20, 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities including Oregon, with a March 26, 2026 proposal deadline. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 for market intelligence on direct-to-manufacturer prescription programs. The code shows no standout repeat buyer and little recent activity relative to the breadth of state and local medical procurement overall.